Loading candles…
Accretion Pharmaceuticals Limited was incorporated in 2012 and operates within the pharmaceutical industry. It develops and manufactures pharmaceutical formulations and services, including tablets, capsules, healthcare products, and therapeutic solutions. The company serves both domestic and international markets, with a focus on niche market categories. Positioned as a mid-sized player, Accretion Pharmaceuticals Limited functions as a key entity within the Indian pharmaceutical landscape. It does not have publicly disclosed founders, key management details, subsidiaries, or listings on stock exchanges.
This page is a live market overview for ACCRETION PHARMA LIMITED (ACCPL) on the NSE. As a listed security, ACCRETION PHARMA LIMITED is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for ACCPL before placing trades on tick2trade.
As of the latest feed, ACCPL last traded at ₹214.95 on NSE, up ₹0 (0.00%) from the previous close of ₹214.95. Today's session range is ₹214.95 – ₹214.95, against a 52-week band of ₹53.8 – ₹219. Traded volume today stands at 1.20K shares.
The overview consolidates an interactive price chart with multiple time ranges, five-level bid and ask depth, upcoming corporate events for ACCPL in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether ACCPL is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for ACCRETION PHARMA LIMITED before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in ACCPL. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated ACCPL option chain page linked from this overview.
| Type | Details | Date |
|---|---|---|
| Index Review | NSE indices rebalancing | 31 Mar 2026 |
| Expiry | Monthly F&O expiry | 30 Jan 2026 |
| Expiry | Monthly F&O expiry | 27 Feb 2026 |
| Holiday | Republic Day — market closed | 26 Jan 2026 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.